Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

Introduction: Hepsin is a type II transmembrane serine protease and its expression has been linked to greater tumorigenicity and worse prognosis in different tumors. Recently, our group demonstrated that high hepsin levels from primary tumor were associated with a higher risk of metastasis and throm...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Maria Carmen Rodenas, Julia Peñas-Martínez, Irene Pardo-Sánchez, David Zaragoza-Huesca, Carmen Ortega-Sabater, Jorge Peña-García, Salvador Espín, Guillermo Ricote, Sofía Montenegro, Francisco Ayala-De La Peña, Ginés Luengo-Gil, Andrés Nieto, Francisco García-Molina, Vicente Vicente, Francesco Bernardi, María Luisa Lozano, Victoriano Mulero, Horacio Pérez-Sánchez, Alberto Carmona-Bayonas, Irene Martínez-Martínez
Format: Artikel
Sprache:English
Veröffentlicht: Frontiers Media S.A. 2023-05-01
Schriftenreihe:Frontiers in Molecular Biosciences
Schlagworte:
hepsin
colorectal cancer
metastasis
thrombosis
molecular-targeted therapy
Online Zugang:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1182925/full

Online

https://www.frontiersin.org/articles/10.3389/fmolb.2023.1182925/full

Ähnliche Einträge